Published in Cancer Med on February 14, 2013
Circulating Tumor DNA Analysis for Liver Cancers and Its Usefulness as a Liquid Biopsy. Cell Mol Gastroenterol Hepatol (2015) 0.86
Murine melanomas accelerated by a single UVR exposure carry photoproduct footprints but lack UV signature C>T mutations in critical genes. Oncogene (2015) 0.76
Identification and analysis of mutational hotspots in oncogenes and tumour suppressors. Oncotarget (2017) 0.75
The biology of uveal melanoma. Cancer Metastasis Rev (2017) 0.75
A somatic GNA11 mutation is associated with extremity capillary malformation and overgrowth. Angiogenesis (2017) 0.75
Genome sequencing in microfabricated high-density picolitre reactors. Nature (2005) 150.21
Accurate whole human genome sequencing using reversible terminator chemistry. Nature (2008) 90.20
Circulating mutant DNA to assess tumor dynamics. Nat Med (2007) 10.33
Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi. Nature (2008) 8.42
Mutations in GNA11 in uveal melanoma. N Engl J Med (2010) 7.52
Detection and quantification of mutations in the plasma of patients with colorectal tumors. Proc Natl Acad Sci U S A (2005) 5.91
DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells. Cancer Res (2001) 5.45
[Not Available]. C R Seances Soc Biol Fil (1948) 3.32
Prognostic implications of monosomy 3 in uveal melanoma. Lancet (1996) 3.26
Oncogenic mutations in GNAQ occur early in uveal melanoma. Invest Ophthalmol Vis Sci (2008) 3.14
Assessment of metastatic disease status at death in 435 patients with large choroidal melanoma in the Collaborative Ocular Melanoma Study (COMS): COMS report no. 15. Arch Ophthalmol (2001) 2.52
Uveal melanoma: epidemiologic aspects. Ophthalmol Clin North Am (2005) 2.24
Detection of circulating tumour DNA in the blood (plasma/serum) of cancer patients. Cancer Metastasis Rev (1999) 2.21
Oncogenic GNAQ mutations are not correlated with disease-free survival in uveal melanoma. Br J Cancer (2009) 1.93
Cell-free DNA in the blood as a solid tumor biomarker--a critical appraisal of the literature. Clin Chim Acta (2010) 1.73
Circulating DNA: a new diagnostic gold mine? Cancer Treat Rev (2002) 1.58
Circulating deoxyribonucleic Acid as prognostic marker in non-small-cell lung cancer patients undergoing chemotherapy. J Clin Oncol (2004) 1.57
High fragmentation characterizes tumour-derived circulating DNA. PLoS One (2011) 1.42
Ultrasensitive measurement of hotspot mutations in tumor DNA in blood using error-suppressed multiplexed deep sequencing. Cancer Res (2012) 1.39
Identification of chromosomes 3, 6, and 8 aberrations in uveal melanoma by microsatellite analysis in comparison to comparative genomic hybridization. Cancer Genet Cytogenet (2000) 1.15
Alu repeat sequences are present in increased proportions compared to a unique gene in plasma/serum DNA: evidence for a preferential release from viable cells? Ann N Y Acad Sci (2001) 1.15
Current status and future potential of somatic mutation testing from circulating free DNA in patients with solid tumours. Hugo J (2011) 1.13
Characterization of circulating DNA in healthy human plasma. Clin Chim Acta (2007) 1.12
Does ocular treatment of uveal melanoma influence survival? Br J Cancer (2010) 1.09
Partial deletions of the long and short arm of chromosome 3 point to two tumor suppressor genes in uveal melanoma. Cancer Res (2001) 1.06
Liver function tests in metastatic uveal melanoma. Am J Ophthalmol (2004) 0.92
Metastatic Melanoma presenting 24 years after surgical resection: a case report and review of the literature. Cases J (2009) 0.90
Pyrophosphorolysis-activated polymerization detects circulating tumor DNA in metastatic uveal melanoma. Clin Cancer Res (2012) 0.85
Atypical Angelman syndrome with macrocephaly due to a familial imprinting center deletion. Am J Med Genet A (2008) 0.82
What hope for the future? GNAQ and uveal melanoma. Br J Ophthalmol (2011) 0.81
Scleral buckling versus primary vitrectomy in rhegmatogenous retinal detachment: a prospective randomized multicenter clinical study. Ophthalmology (2007) 3.47
Characterisation of retinoblastomas without RB1 mutations: genomic, gene expression, and clinical studies. Lancet Oncol (2013) 2.32
Tumor classification based on gene expression profiling shows that uveal melanomas with and without monosomy 3 represent two distinct entities. Cancer Res (2003) 2.18
Exome sequencing identifies recurrent somatic mutations in EIF1AX and SF3B1 in uveal melanoma with disomy 3. Nat Genet (2013) 2.05
Choroidal metastasis in disseminated lung cancer: frequency and risk factors. Am J Ophthalmol (2002) 1.86
Primary vitrectomy for rhegmatogenous retinal detachment: an analysis of 512 cases. Graefes Arch Clin Exp Ophthalmol (2005) 1.79
The human retinoblastoma gene is imprinted. PLoS Genet (2009) 1.63
Hypothermia does not alter somatosensory evoked potential amplitude and global cerebral oxygen extraction during marked sodium nitroprusside-induced arterial hypotension. Anesthesiology (2003) 1.53
Chemosensitivity of conjunctival melanoma cell lines to target-specific chemotherapeutic agents. Graefes Arch Clin Exp Ophthalmol (2012) 1.42
Biopsy in indeterminate intraocular tumors. Ophthalmology (2002) 1.37
Secondary acute myelogenous leukemia in patients with retinoblastoma: is chemotherapy a factor? Ophthalmology (2007) 1.33
External beam radiotherapy of choroidal metastases--final results of a prospective study of the German Cancer Society (ARO 95-08). Radiother Oncol (2002) 1.32
Prognostic value of clinical and histopathological parameters in conjunctival melanomas: a retrospective study. Br J Ophthalmol (2002) 1.22
A comprehensive molecular study on Coffin-Siris and Nicolaides-Baraitser syndromes identifies a broad molecular and clinical spectrum converging on altered chromatin remodeling. Hum Mol Genet (2013) 1.22
Implantation and explantation of a wireless epiretinal retina implant device: observations during the EPIRET3 prospective clinical trial. Invest Ophthalmol Vis Sci (2009) 1.21
Primary intraocular lymphoma of T-cell type: report of a case and review of the literature. Graefes Arch Clin Exp Ophthalmol (2004) 1.12
Visual loss following intraocular gas injection. Dtsch Arztebl Int (2008) 1.09
Low frequency of imprinting defects in ICSI children born small for gestational age. Eur J Hum Genet (2008) 1.05
A method and technical equipment for an acute human trial to evaluate retinal implant technology. J Neural Eng (2005) 1.04
Histopathologic findings of eyes enucleated after treatment with chemosurgery for retinoblastoma. Open Ophthalmol J (2011) 1.03
Expression of HSP 90, PTEN and Bcl-2 in conjunctival melanoma. Br J Ophthalmol (2010) 1.02
Genotype-phenotype correlations in patients with retinoblastoma and interstitial 13q deletions. Eur J Hum Genet (2011) 1.01
Positive interaction between light iris color and ultraviolet radiation in relation to the risk of uveal melanoma: a case-control study. Ophthalmology (2008) 1.00
Lack of SF3B1 R625 mutations in cutaneous melanoma. Diagn Pathol (2013) 1.00
Aberrant hypomethylation of the cancer-testis antigen PRAME correlates with PRAME expression in acute myeloid leukemia. Ann Hematol (2008) 0.98
Somatic mosaicism in patients with Angelman syndrome and an imprinting defect. Hum Mol Genet (2004) 0.97
Intraocular biopsy using special forceps: a new instrument and refined surgical technique. Br J Ophthalmol (2011) 0.97
Phase II trial of cisplatin, gemcitabine and treosulfan in patients with metastatic uveal melanoma. Melanoma Res (2005) 0.96
A variant allele of Growth Factor Independence 1 (GFI1) is associated with acute myeloid leukemia. Blood (2010) 0.96
Quantification of regulatory T cells in septic patients by real-time PCR-based methylation assay and flow cytometry. PLoS One (2012) 0.96
Iodine 125 plaque brachytherapy versus transscleral tumor resection in the treatment of large uveal melanomas. Ophthalmology (2002) 0.95
Higher vessel densities in retinoblastoma with local invasive growth and metastasis. Am J Pathol (2004) 0.95
Loss of heterozygosity of 1p in uveal melanomas with monosomy 3. Int J Cancer (2005) 0.94
Long-term effect of acetazolamide treatment of patients with uveitic chronic cystoid macular edema is limited by persisting inflammation. Retina (2005) 0.91
Combined phacoemulsification and pars plana vitrectomy: clear corneal versus scleral incisions: prospective randomized multicenter study. J Cataract Refract Surg (2003) 0.91
The treatment of wet age-related macular degeneration. Dtsch Arztebl Int (2009) 0.91
Proton radiotherapy as an alternative to exenteration in the management of extended conjunctival melanoma. Graefes Arch Clin Exp Ophthalmol (2005) 0.91
Assessment of genomic instability in breast cancer and uveal melanoma by random amplified polymorphic DNA analysis. Int J Cancer (2002) 0.89
Imprinting of RB1 (the new kid on the block). Brief Funct Genomics (2010) 0.89
Case-control study on uveal melanoma (RIFA): rational and design. BMC Ophthalmol (2004) 0.88
Combining DNA expression with positional information to detect functional silencing of chromosomal regions. Bioinformatics (2003) 0.87
Second cranio-facial malignancies in hereditary retinoblastoma survivors previously treated with radiation therapy: clinic and radiologic characteristics and survival outcomes. Eur J Cancer (2013) 0.86
Angiographic findings following tack fixation of a wireless epiretinal retina implant device in blind RP patients. Graefes Arch Clin Exp Ophthalmol (2011) 0.86
Novel cell lines derived by long-term culture of primary uveal melanomas. Ophthalmologica (2009) 0.86
[Endogenous bacterial endophthalmitis: a retrospective study on 22 consecutive cases]. Klin Monbl Augenheilkd (2004) 0.85
Establishment and characterization of two uveal melanoma cell lines derived from tumors with loss of one chromosome 3. Exp Eye Res (2006) 0.85
Acute electrical stimulation of the human retina with an epiretinal electrode array. Acta Ophthalmol (2011) 0.84
The impact of diagnosis and plaque radiotherapy treatment of malignant choroidal melanoma on patients' quality of life. Psychooncology (2006) 0.84
Risk of uveal melanoma. Ophthalmology (2007) 0.84
Quality of life in patients with malignant choroidal melanoma after radiotherapy. Graefes Arch Clin Exp Ophthalmol (2003) 0.84
BAP1 germline mutation in two first grade family members with uveal melanoma. Br J Ophthalmol (2013) 0.84
Human PPP1R26P1 functions as cis-repressive element in mouse Rb1. PLoS One (2013) 0.83
Long-term results after surgical extraction of subfoveal choroidal neovascular membranes with and without haemorrhage in age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol (2004) 0.83
Impact of 5-aza-2'-deoxycytidine and epigallocatechin-3-gallate for induction of human regulatory T cells. Immunology (2014) 0.83
EFS shows biallelic methylation in uveal melanoma with poor prognosis as well as tissue-specific methylation. BMC Cancer (2011) 0.83
Mobile phone use and risk of uveal melanoma: results of the risk factors for uveal melanoma case-control study. J Natl Cancer Inst (2009) 0.83
Two brothers with Burn-McKeown syndrome. Clin Dysmorphol (2003) 0.83
A new face of Borjeson-Forssman-Lehmann syndrome? De novo mutations in PHF6 in seven females with a distinct phenotype. J Med Genet (2013) 0.82
Development of surgical techniques for implantation of a wireless intraocular epiretinal retina implant in Göttingen minipigs. Graefes Arch Clin Exp Ophthalmol (2011) 0.82
[Brivudine as an alternative systemic therapy to aciclovir and ganciclovir in acute retinal necrosis syndrome due to varicella-zoster virus]. Klin Monbl Augenheilkd (2003) 0.82
Cooking and uveal melanoma risk: results from two German case-control studies. Cancer Causes Control (2003) 0.82
Photodynamic therapy in retinoblastoma: effects of verteporfin on retinoblastoma cell lines. Invest Ophthalmol Vis Sci (2008) 0.82
Monte Carlo simulations applied to conjunctival lymphoma radiotherapy treatment. Strahlenther Onkol (2011) 0.81
Loss at chromosome arm 16q in retinoblastoma: confirmation of the association with diffuse vitreous seeding and refinement of the recurrently deleted region. Genes Chromosomes Cancer (2011) 0.81
Chronically implanted epidural electrodes in Göttinger minipigs allow function tests of epiretinal implants. Graefes Arch Clin Exp Ophthalmol (2003) 0.81
De novo intraocular retinoblastoma development after chemotherapy in patients with hereditary retinoblastoma. Retina (2006) 0.81
Population-based incidence estimates of uveal melanoma in Germany. Supplementing cancer registry data by case-control data. Eur J Cancer Prev (2006) 0.81
Beta-ray brachytherapy with 106Ru plaques for retinoblastoma. Int J Radiat Oncol Biol Phys (2006) 0.81
Beta-ray brachytherapy of retinoblastoma: feasibility of a new small-sized ruthenium-106 plaque. Ophthalmic Res (2005) 0.80
Photodynamic therapy using verteporfin for choroidal neovascularization associated with angioid streaks--long-term effects. Ophthalmic Res (2006) 0.80
The origin of the RB1 imprint. PLoS One (2013) 0.80
Development of very large electrode arrays for epiretinal stimulation (VLARS). Biomed Eng Online (2014) 0.80
The role of photodynamic therapy in the treatment of symptomatic choroidal hemangioma. Graefes Arch Clin Exp Ophthalmol (2005) 0.79
Chemoreduction improves eye retention in patients with retinoblastoma: a report from the German Retinoblastoma Reference Centre. Br J Ophthalmol (2013) 0.79
A case-control study: occupational cooking and the risk of uveal melanoma. BMC Ophthalmol (2010) 0.79
The design and the dosimetry of bi-nuclide radioactive ophthalmic applicators. Med Phys (2004) 0.79
Differential expression of tissue inhibitor of matrix metalloproteinases 3 in uveal melanoma. Ophthalmic Res (2005) 0.79
FOLFIRI and sunitinib as first-line treatment in metastatic colorectal cancer patients with liver metastases--a CESAR phase II study including pharmacokinetic, biomarker, and imaging data. Int J Clin Pharmacol Ther (2014) 0.79
Inhibitor of apoptosis proteins gene expression and its correlation with prognostic factors in primary and metastatic uveal melanoma. Curr Eye Res (2008) 0.78
Expression of classic and nonclassic HLA class I antigens in uveal melanoma. Invest Ophthalmol Vis Sci (2003) 0.78
Diagnostic image quality of gadolinium-enhanced T1-weighted MRI with and without fat saturation in children with retinoblastoma. Pediatr Radiol (2013) 0.78
Expression of MCSP and PRAME in conjunctival melanoma. Br J Ophthalmol (2010) 0.78
Independent prognostic factors for distant metastases and survival in patients with primary uveal melanoma. Eur J Cancer (2004) 0.78
High-resolution MRI using orbit surface coils for the evaluation of metastatic risk factors in 143 children with retinoblastoma: Part 2: new vs. old imaging concept. Neuroradiology (2015) 0.78
DNA methylation in promoter regions of red cell membrane protein genes in healthy individuals and patients with hereditary membrane disorders. Int J Hematol (2005) 0.78
The spatial distribution of monosomy 3 and network vasculogenic mimicry patterns in uveal melanoma. Invest Ophthalmol Vis Sci (2007) 0.78
Comparing the Prognostic Value of BAP1 Mutation Pattern, Chromosome 3 Status, and BAP1 Immunohistochemistry in Uveal Melanoma. Am J Surg Pathol (2016) 0.78
FOXP3 Expression in GARP-Transduced Helper T Cells Is Not Associated with FOXP3 TSDR Demethylation. Transfus Med Hemother (2011) 0.77
Surgical Results and Microscopic Analysis of the Tissue Reaction following Implantation and Explantation of an Intraocular Implant for Epiretinal Stimulation in Minipigs. Ophthalmic Res (2011) 0.77
Having children, social characteristics, smoking and the risk of uveal melanoma: a case-control study. Ophthalmic Epidemiol (2013) 0.77
Cadherin expression in uveal melanoma. Exp Eye Res (2002) 0.77
Relationships between DNA methylation and expression in erythrocyte membrane protein (band 3, protein 4.2, and beta-spectrin) genes during human erythroid development and differentiation. Int J Hematol (2005) 0.77